J05AF (Direct acting antivirals)
GPTKB entity
Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:ATCCode |
J05AF
|
| gptkbp:class |
gptkb:Anatomical_Therapeutic_Chemical_Classification_System
|
| https://www.w3.org/2000/01/rdf-schema#label |
J05AF (Direct acting antivirals)
|
| gptkbp:includes |
J05AF01 (Zidovudine)
J05AF02 (Didanosine) J05AF03 (Zalcitabine) J05AF04 (Stavudine) J05AF05 (Lamivudine) J05AF06 (Abacavir) J05AF07 (Emtricitabine) |
| gptkbp:partOf |
ATC code J05 (Antivirals for systemic use)
|
| gptkbp:usedFor |
treatment of viral infections
|
| gptkbp:bfsParent |
gptkb:J05AF05
gptkb:J05AF03 |
| gptkbp:bfsLayer |
7
|